Gough Au

Post Doctoral Scientist

Newcastle Innovation

Location
Newcastle, Australia
Discipline
Biological Sciences
Interests
Oncolytic Virotherapy
more... less...

About

Dr Gough Au is an early career researcher and currently appointed as a NHMRC Industry Research fellow (2007-2011). He is carrying out his four-year term in conjunction with The University of Newcastle and industry partner Viralytics Ltd. Gough's main research interest is in the development of naturally occurring viruses with selective anti-cancer properties, for the treatment of melanoma, multiple myeloma and malignant glioma.
more... less...

Publications

Novel marker for recombination in the 3'-untranslated region of members of the species Human enterovirus A.

Kok C, Au G

Archives of virology (2012)

  • -- Readers Readers not available. This publication is not currently accessible in the Mendeley catalog.

Oncolysis of malignant human melanoma tumors by Coxsackieviruses A13, A15 and A18

Au G, Beagley L, Haley E, Barry R, Shafren D

Virology Journal (2011)

  • -- Readers Readers not available. This publication is not currently accessible in the Mendeley catalog.

Localisation of tachykinin NK1 and NK3 receptors in the human prefrontal and visual cortex.

Tooney P, Au G, Chahl L

Neuroscience letters (2000)

  • -- Readers Readers not available. This publication is not currently accessible in the Mendeley catalog.

Tachykinin NK1 and NK3 receptors in the prefrontal cortex of the human brain.

Tooney P, Au G, Chahl L

Clinical and experimental pharmacology & physiology (2000)

  • -- Readers Readers not available. This publication is not currently accessible in the Mendeley catalog.

Systemic therapy of malignant human melanoma tumors by a common cold-producing enterovirus, coxsackievirus a21.

Shafren D, Au G, Nguyen T, Newcombe N, Haley E, Beagley L et al.

Clinical cancer research : an official journal of the American Association for Cancer Research (2004)

  • -- Readers Readers not available. This publication is not currently accessible in the Mendeley catalog.

Potent oncolytic activity of human enteroviruses against human prostate cancer.

Berry L, Au G, Barry R, Shafren D

The Prostate (2008)

  • -- Readers Readers not available. This publication is not currently accessible in the Mendeley catalog.

Regional administration of oncolytic Echovirus 1 as a novel therapy for the peritoneal dissemination of gastric cancer.

Haley E, Au G, Carlton B, Barry R, Shafren D

Journal of molecular medicine (Berlin, Germany) (2009)

  • -- Readers Readers not available. This publication is not currently accessible in the Mendeley catalog.

Oncolytic Coxsackievirus A21 as a novel therapy for multiple myeloma.

Au G, Lincz L, Enno A, Shafren D

British journal of haematology (2007)

  • -- Readers Readers not available. This publication is not currently accessible in the Mendeley catalog.

Oncolysis of vascular malignant human melanoma tumors by Coxsackievirus A21.

Au G, Lindberg a, Barry R, Shafren D

International journal of oncology (2005)

  • -- Readers Readers not available. This publication is not currently accessible in the Mendeley catalog.

Professional experience

Post Doctoral Scientist

Newcastle Innovation

May 2011 - Present

Post Doctoral Scientist

The University of Newcastle, Australia

May 2007 - May 2011 (4 years)

Research Director

The University of Newcastle Research Associates (TUNRA) now Newcastle Innovation

August 2004 - May 2007 (2 years 9 months)

Education history

The University of Newcastle, Australia

Doctor of Philosophy [Immunology & Microbiology]

February 2001 - September 2005 (4 years 7 months)

The University of Newcastle, Australia

Bachelor of Biomedical Science [Honours]

March 2000 - December 2000 (9 months)

The University of Newcastle, Australia

Bachelor of Biomedical Science

March 1997 - December 1999 (2 years 9 months)